{
  "success": true,
  "pagesUsed": [
    0,
    1,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    41,
    42,
    43,
    44,
    45,
    46
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Atezolizumab",
        "type": {
          "id": "7160df3a-b6cd-4866-b2bf-7f43198582dc",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "ba1ca788-4b12-49dc-8740-45d13e6c2933",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-L1 antibody (MPDL3280A) administered in combination with paclitaxel.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "efccf010-668c-47a1-98c3-a341b26ed21c",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "3210e85f-f6cc-4f1f-8833-4083070d47a5",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo consisting of the vehicle without the antibody.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Paclitaxel",
        "type": {
          "id": "bbccf28f-c068-402b-82c5-4731d3ee01a9",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "ab5b03db-2d5b-4c1c-86df-da10c94ae0b9",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Standard chemotherapy administered as background therapy in both study arms.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Dexamethasone",
        "type": {
          "id": "08330c83-c0b7-43ff-ac00-9e2b17d45ea6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "609ab00b-3b52-4d45-af93-f9099e78caa6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required premedication for paclitaxel to prevent hypersensitivity reactions.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Diphenhydramine",
        "type": {
          "id": "1bae0f4e-f3ba-4db7-b8a8-e99e3942e69b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7b71b84e-d3cb-49c5-9ff3-f9c5b47e8c54",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required premedication for paclitaxel (antihistamine)."
      },
      {
        "id": "int_6",
        "name": "Cimetidine",
        "type": {
          "id": "72945239-c7cc-4c76-95f6-12556ec2602f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "364db584-0fce-4428-b1b6-e002f08ae960",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "id": "int_7",
        "name": "Ranitidine",
        "type": {
          "id": "fda09286-ab18-48e3-b286-63b217f1d5aa",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "72379c2b-2f00-407e-b372-5c3192749252",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Alternative required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "id": "int_8",
        "name": "Chinese traditional medicines",
        "type": {
          "id": "68dde570-0ce5-4305-905c-b6bfc93f5e76",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "33479599-fe1a-4ba2-b4aa-00723508ca4c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for China Population if last administration was at least 2 weeks prior to randomisation."
      },
      {
        "id": "int_9",
        "name": "Systemic immunosuppressive medications",
        "type": {
          "id": "2ef7ca37-66f6-45f1-9b78-293c9fba3018",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "13622bdc-33e5-4399-9d5d-092e07a340cd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 2 weeks prior to randomisation (includes cyclophosphamide, azathioprine, cyclosporine, methotrexate, thalidomide, and anti-TNF agents)."
      },
      {
        "id": "int_10",
        "name": "Live, attenuated vaccine",
        "type": {
          "id": "a6bf30e5-e9bc-4642-a2dc-279314143496",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8d6e4262-10df-4598-92c9-52310cf31840",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 4 weeks prior to randomisation and during the study."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Atezolizumab",
        "administrableDoseForm": {
          "id": "2d163955-fd4e-482e-be2b-86ac81e54fbf",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "0d07dd37-058d-4fa2-8738-b141bd5a7242",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "68f7124b-bdae-4682-8373-f2ac1038aadf",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "60 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "id": "prod_2",
        "name": "Placebo",
        "administrableDoseForm": {
          "id": "a2122f9f-8321-41ab-a545-9a92013fb241",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "804ab815-350d-496d-b412-3ba841620df4",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8732cf03-7221-4eb1-b3b7-b565b080b4f8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "0 mg/mL",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "id": "prod_3",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "b76490ff-bf43-4368-a1df-57fa1eb4beda",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "50152734-171a-449e-b6ef-8d6817e0390b",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "ea70f517-dec3-4818-8571-e59cde1a905e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Atezolizumab/Placebo Regimen",
        "instanceType": "Administration",
        "dose": "840 mg",
        "doseFrequency": "Days 1 and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Paclitaxel Regimen",
        "instanceType": "Administration",
        "dose": "90 mg/m2",
        "doseFrequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or end of study"
      },
      {
        "id": "admin_3",
        "name": "Dexamethasone Premedication (Oral)",
        "instanceType": "Administration",
        "dose": "8-10 mg",
        "doseFrequency": "12 and 6 hours prior to paclitaxel infusion",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Prior to first two infusions (then minimized)"
      },
      {
        "id": "admin_4",
        "name": "Dexamethasone Premedication (IV)",
        "instanceType": "Administration",
        "dose": "10 mg",
        "doseFrequency": "Within 1 hour prior to paclitaxel infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "If oral dose missed"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Atezolizumab",
        "instanceType": "Substance",
        "description": "Humanised IgG1 monoclonal antibody that targets PD-L1"
      },
      {
        "id": "sub_2",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Cytotoxic chemotherapy agent"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "PleurX",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 10,
      "productCount": 3,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Atezolizumab",
        "role": "Investigational Product",
        "description": "Anti-PD-L1 antibody (MPDL3280A) administered in combination with paclitaxel."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo consisting of the vehicle without the antibody."
      },
      {
        "name": "Paclitaxel",
        "role": "Background Therapy",
        "description": "Standard chemotherapy administered as background therapy in both study arms."
      },
      {
        "name": "Dexamethasone",
        "role": "Concomitant Medication",
        "description": "Required premedication for paclitaxel to prevent hypersensitivity reactions."
      },
      {
        "name": "Diphenhydramine",
        "role": "Concomitant Medication",
        "description": "Required premedication for paclitaxel (antihistamine)."
      },
      {
        "name": "Cimetidine",
        "role": "Concomitant Medication",
        "description": "Required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "name": "Ranitidine",
        "role": "Concomitant Medication",
        "description": "Alternative required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "name": "Chinese traditional medicines",
        "role": "Concomitant Medication",
        "description": "Permitted for China Population if last administration was at least 2 weeks prior to randomisation."
      },
      {
        "name": "Systemic immunosuppressive medications",
        "role": "Concomitant Medication",
        "description": "Prohibited within 2 weeks prior to randomisation (includes cyclophosphamide, azathioprine, cyclosporine, methotrexate, thalidomide, and anti-TNF agents)."
      },
      {
        "name": "Live, attenuated vaccine",
        "role": "Concomitant Medication",
        "description": "Prohibited within 4 weeks prior to randomisation and during the study."
      }
    ],
    "products": [
      {
        "name": "Atezolizumab",
        "doseForm": "Solution",
        "strength": "60 mg/mL",
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "name": "Placebo",
        "doseForm": "Solution",
        "strength": "0 mg/mL",
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Solution",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Atezolizumab",
        "description": "Humanised IgG1 monoclonal antibody that targets PD-L1"
      },
      {
        "name": "Paclitaxel",
        "description": "Cytotoxic chemotherapy agent"
      }
    ],
    "administrations": [
      {
        "name": "Atezolizumab/Placebo Regimen",
        "dose": "840 mg",
        "frequency": "Days 1 and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Paclitaxel Regimen",
        "dose": "90 mg/m2",
        "frequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or end of study"
      },
      {
        "name": "Dexamethasone Premedication (Oral)",
        "dose": "8-10 mg",
        "frequency": "12 and 6 hours prior to paclitaxel infusion",
        "route": "Oral",
        "duration": "Prior to first two infusions (then minimized)"
      },
      {
        "name": "Dexamethasone Premedication (IV)",
        "dose": "10 mg",
        "frequency": "Within 1 hour prior to paclitaxel infusion",
        "route": "Intravenous",
        "duration": "If oral dose missed"
      }
    ],
    "devices": [
      {
        "name": "PleurX",
        "manufacturer": "Not specified",
        "purpose": "Indwelling catheter for management of pleural effusion"
      }
    ]
  }
}